The emerging potential of advanced OCT-based biomarkers
Neuronal loss of ganglion cells in the retina is an established hallmark of a number of diseases. As such, a number of clinical trials use the ganglion cell layer (GCL) thickness - or a complex thereof - as measured with optical coherence tomography (OCT) imaging as a biomarker. For example,…
Orion in action!
Researchers in Barcelona at the August Pi i Sunyer Biomedical Research Institute (IDIBAPS) recently used OrionTM to demonstrate inner retinal biomarkers for prediction of visual function loss in non-arteritic ischaemic optic neuropathy. For more information please see the paper or the OctNews release.
Orion is released!
We are very excited to announce the release of Orion, our advanced OCT analysis software. For more information, please visit: https://voxeleron.com/orion/ or see our press release: http://www.prweb.com/releases/2015/02/prweb12513586.htm
Some Notes from: Glaucoma 360 – New Horizons Forum
On Friday the 6th of February, I attended the Glaucoma 360 New Horizons forum, a meeting bringing together clinicians, scientists, venture capitalists, as well as representatives from device manufacturers, pharmaceutical companies and the FDA. Typically, the Friday meeting’s focus – at least in the three years that I have attended…
Orion wins innovation award!
We are very pleased to announce that Orion, our OCT analysis software, has made the Ophthalmologist’s 2014 Innovation awards! Judges’ comments: “Good alternative in hospitals with different OCT manufacturers to have same software for evaluation. https://theophthalmologist.com/issues/the-stars-of-2014/
The eye is a window to the brain; but who’s looking?
As an extension of the central nervous system, the eye offers a window to the brain. Since the advent of optical coherence tomography (OCT) imaging, in vivo cross-sectional imaging of the human retina has become commonplace, facilitating quantitative measurements of neuronal layer thicknesses at the micron scale. Pioneering work by…
Orion is in beta – Voxeleron prepares the release of their advanced OCT analysis software
Orion™, Voxeleron’s advanced optical coherence tomography (OCT) analysis software, is currently being beta tested at a number of sites in the USA and Europe in preparation for release. Orion™ is an application that offers fully-automated, rapid and accurate segmentation of seven layers in OCT images of the human retina. Following…
Optical Coherence Tomography Imaging of Diseases of the Central Nervous System
The eye as a window to the central nervous system Optical coherence tomography (OCT) is a non-invasive, non-contact structural imaging modality (Huang D, 1991), that has unique utility in a number of life science applications. In ophthalmology it is used to generate in vivo, micron scale, cross-sectional imagery of ocular…
New Research Sets the Stage for Noninvasive Monitoring of HIV-Induced Peripheral Neuropathy
Corneal nerve fiber assessment proposed for managing patients with HIV-induced peripheral neuropathy, according to The American Journal of Pathology Philadelphia, PA, May 12, 2014 – Corneal nerve fiber assessment has great potential as a tool to diagnose and monitor peripheral neuropathy induced by HIV, say scientists at the Johns Hopkins…
